The gallery will be a part of the HLTH Europe event and will be open to all attendees.
No More Barriers
Doug Healy
Healthcare brings out the artist in pharma.
HLTH Inc. announced its own art gallery, sponsored by GE HealthCare. In a press release, HLTH Inc. revealed that the gallery will be part of its inaugural HLTH Europe event, which will occur from June 17-20, 2024 in Amsterdam. The gallery will be open throughout the entire event and will be available to all attendees.
In a press release, HLTH Europe’s managing director Katy Fryatt said, “We are thrilled to launch the HLTH Europe Art Gallery with the support of the GE HealthCare team. Art is a powerful medium through which we can share our experiences and connect with each other. We encourage submissions from all stakeholders in the healthcare ecosystem from patient groups to care givers, clinicians and system leaders. The gallery will foster a sense of community among the whole healthcare ecosystem through art. Ultimately, we hope the gallery offers a reminder about why we are coming together at HLTH–for the benefit of patients."
HLTH is accepting submissions for the gallery from HCPs, patients, and caregivers. The gallery will include a variety of mediums, including paintings, digital art, and photography. Attendees of the gallery will also have access to interactive workshops on various visual art methods.
Simon Philip Rost, Chief Marketing Officer Enterprise Imaging, GE HealthCare, says, "We are proud to be part of this initiative at HLTH Europe. We recognise the therapeutic power of art and its contribution to patients' holistic wellbeing and would encourage everyone in the healthcare ecosystem to consider submitting their work. We look forward to providing a creative outlet for patients and healthcare professionals alike later this year in Amsterdam."
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.